Quay Pharma is one of the world’s leading Contract Development and Manufacturing Organisations. Based in the UK, we provide specialist services to the pharmaceutical and biotech industries built on our unique expertise in drug formulation development, analytical services and contract manufacturing for clinical and specials products.
Within Quay Pharma we can provide virtually all of the services required to bring drug products through the various stages of clinical development quickly and cost effectively, and we have the expertise to give each product the best possible chance of success by optimizing its delivery mechanism. Our experienced analytical team is on hand to provide all the support required through each stage of development and manufacturing.
Our fee structure is transparent, with clearly set out costs for specific stages, and we can contribute from the preclinical stage through to formulation and dosage form development and optimization. In addition, we can provide a full manufacturing and packaging service covering Phase I, Phase II, Phase III and small scale commercial manufacturing from our accredited MHRA and FDA approved GMP facilities.
By drawing on our considerable experience of developing new dosage forms for new indications or different patient populations, we can also help organisations who want to reformulate or reposition existing drug products. In addition, our GMP capabilities can be used for scale-up manufacturing, specials manufacturing and even small-scale commercial manufacturing.